March 7 (Reuters) - The U.S. Food and Drug Administration has granted accelerated approval for the expanded use of BeiGene's combination drug to treat certain patients with a type of blood cancer, the health regulator said on Thursday. (Reporting by Sriparna Roy, Sneha S K and Mariam Sunny in Bengaluru; Editing by Devika Syamnath and Shounak Dasgupta)
Stock Market News
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
153.6 USD | +0.47% | +5.20% | 16.26B | ||
2,881 PTS | -1.17% | -1.64% | - | ||
- Stock Market
- Stock Market News
- Economy
- US FDA approves expanded use of BeiGene's blood cancer drug